A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients

Overview of attention for article published in Journal of Neuro-Oncology, October 2015

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 537 followers.

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients http://t.co/xZ4BZubw3N

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.